Perfusion-weighted MR Imaging in Cerebral Lupus Erythematosus

Academic Radiology

Volumn 19, Issue 8, 2012, Pages 965-970

  Wang, Page I ^a   Cagnoli, Patricia C ^a   McCune, William J ^a   Schmidt Wilcke, Tobias ^b   Lowe, Suzan E ^a   Graft, Courtney C ^a   Gebarski, Stephen S ^a   Chenevert, Thomas L ^a   Khalatbari, Shokoufeh ^c   Myles, James D ^c   Watcharotone, Kuanwong ^c   Cronin, Paul ^a   Sundgren, Pia C ^a,d  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Lupus; MRI; Neuropsychiatric lupus; Perfusion; SLE

Indexed keywords

CONTRAST MEDIUM; DOUBLE STRANDED DNA; IMMUNOSUPPRESSIVE AGENT; SEROTONIN UPTAKE INHIBITOR; STEROID;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN REGION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; GRAY MATTER; HUMAN; LABORATORY TEST; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; WHITE MATTER;

ADULT; BRAIN; BRAIN DISEASES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863448726     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2012.03.023     Document Type: Article

References (25)

1. Bruyn G.A. Controversies in lupus: nervous system involvement. Ann Rheum Dis 1995, 54(3):159-167.
2. Kovacs J.A., Urowitz M.B., Gladman D.D. Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am 1993, 19(4):795-814.
3. Bertsias G.K., Ioannidis J.P.A., Aringer M., et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010, 69(12):2074-2082.
4. Hanly J., McCurdy G., Fougere L., et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004, 31(11):2156-2162.
5. Harel L., Sandborg C., Lee T., et al. Neuropsychiatric manifestations in pediatric systemic lupus erythematosus and association with antiphospholipid antibodies. J Rheumatol 2006, 33(9):1873-1877.
6. Bernatsky S., Clarke A., Gladman D.D., et al. Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus 2006, 15(12):835-839.
7. Gasparovic C., Roldan C., Sibbitt W., et al. Elevated cerebral blood flow and volume in systemic lupus measured by dynamic susceptibility contrast magnetic resonance imaging. J Rheumatol 2010, 37(9):1834-1843.
8. Borrelli M., Tamarozzi R., Colamussi P., et al. Evaluation with MR, perfusion MR and cerebral flowSPECT in NPSLE patients. Radiol Med 2003, 105(5-6):482-489.
9. Emmer B., van Osch M., Wu O., et al. Perfusion MRI in neuro-psychiatric systemic lupus erythematosus. J Magn Res Imaging 2010, 32(2):283-288.
10. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40(9):1725.
11. Mouannes-Srour J.J., Shin W., Ansari S.A., et al. Correction for arterial-tissue delay and dispersion in absolute quantitative cerebral perfusion DSC MR imaging. Magn Reson Med 2011 Dec 12, [Epub ahead of print].
12. Sundgren P.C., Jennings J., Attwood J.T., et al. MRI and 2D-CSI MR spectroscopy of the brain in the evaluation of patients with acute onset of neuropsychiatric systemic lupus erythematosus. Neuroradiology 2005, 47(8):576-585.
13. Folstein M.F., Folstein S.E., McHugh P.R. " Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12(3):189-198.
14. Gladman D., Ginzler E., Goldsmith C., et al. The development and initial validation of the systemic lupus international collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996, 39(3):363-369.
15. Waterloo K., Omdal R., Sjoholm H., et al. Neuropsychological dysfunction in systemic lupus erythematosus is not associated with changes in cerebral blood flow. J Neurol 2001, 248:595-602.
16. Rubbert A., Marienhagen J., Pierner K., et al. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993, 36:1253-1262.
17. Ainiala H., Hietaharju A., Loukkola J., et al. Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum 2001, 45(5):419-423.
18. Hanly J., Su L., Farewell V., et al. Prospective study of neuropsychiatric events in systemic lupus erythematosus. J Rheumatol 2009, 36(7):1449-1459.
19. Hanly J.G., Urowitz M.B., Su L., et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2010, 69(3):529-535.
20. Lee P., Joo U., Bang O., et al. Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism. Neurology 2004, 63(2):395-396.
21. Khubchandani R.P., Viswanathan V., Desai J. Unusual neurologic manifestations (I): parkinsonism in juvenile SLE. Lupus 2007, 16(8):572-575.
22. Emmi L., Bramati M., De Cristofaro M.T., et al. MRI and SPECT investigations of the CNS in SLE patients. Clin Exp Rheumatol 1993, 11(1):13-20.
23. Calamante F., Gadian D.G., Connelly A. Quantification of perfusion using bolus tracking magnetic resonance imaging in stroke: assumptions, limitations, and potential implications for clinical use. Stroke 2002, 33(4):1146-1151.
24. Nossent J.C., Hovestdt A., Schonfeld D.H., et al. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum 1991, 34:1397-1403.
25. Bombardier C., Gladman D.D., Urowitz M.B., et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992, 35(6):630-640.